FIELD: medicine, pharmaceutics.
SUBSTANCE: there is offered application of octenidine dihydrochloride for making a semisolid pharmaceutical compositions for wound repair, treatment of atopic dermatitis, infected eczema, dermatomycosis, vaginal infections, acne, herpes and/or control of pathogenic germs resistant to many medicinal preparations where the composition contains 0.005 to 5 wt % of octenidine dihydrochloride, propylene glycol, hydroxypropyl cellulose and water.
EFFECT: declared composition contains a high portion of water-retaining components that is required for wet wounds repair and exhibits adequate action after 1-minute contact to all tested germs, fungi and bacteria.
4 cl, 5 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL PREPARATION FOR LOCAL AND EXTERNAL USE, BASED ON LOW-MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2348400C1 |
| PHARMACEUTICAL COMBINED COMPOSITION FOR LOCAL AND EXTERNAL USE ON BASIS OF DIOXIDINE | 2016 |
|
RU2667974C2 |
| LOCAL AND EXTERNAL PHARMACEUTICAL PRODUCT BASED OF LOW MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2353354C1 |
| PHARMACEUTICAL PREPARATION FOR LOCAL AND EXTERNAL APPLICATION BASED ON LOW-MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2351322C1 |
| PHARMACEUTICAL COMBINED COMPOSITION FOR LOCAL AND EXTERNAL USE ON BASIS OF BACTERIOLYTIC AND PROTEOLYTIC COMPLEX OF ENZYMES | 2016 |
|
RU2655808C2 |
| PHARMACEUTICAL PREPARATION FOR LOCAL AND EXTERNAL APPLICATION ON BASIS OF LOW-MOLECULAR INDUCTOR OF INTERFERON | 2007 |
|
RU2352330C1 |
| VAGINAL COMPOSITIONS FOR INFECTION TREATMENT | 2005 |
|
RU2385720C2 |
| CYCLOPHERONE-BASED PHARMACEUTICAL COMPOSITION OF LOCAL OR EXTERNAL APPLICATION FOR TREATMENT OF PURULENT-DESTRUCTIVE AFFECTION OF MUCOUS MEMBRANE AND SKIN, GENERAL-SYSTEM DISEASES IN CASE OF IMMUNODEFICIENCY CONDITIONS (VERSIONS) | 2008 |
|
RU2414221C2 |
| PHARMACEUTICAL COMBINED COMPOSITION FOR THE TREATMENT OF PURULENT WOUNDS ON THE BASIS OF FLUOROQUINOLONS (OPTIONS) | 2016 |
|
RU2682171C2 |
| MEDICINE, PHARMACEUTICAL COMPOSITION, METHOD OF TREATING UROGENITAL DISEASES OF THE HUMAN BODY CAUSED BY MICROORGANISMS OF THE UREAPLASMA UREALYTICUM TYPE | 2017 |
|
RU2677686C1 |
